ConductScience.org, home

Paper41360809

Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms.

Pineda-Peña AC and 7 others. NPJ Vaccines, 2025. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms. Papers, record 41360809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41360809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms.
PubMed
Journal
NPJ Vaccines
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
2.93, provisional
iCite
Revised in PubMed
2025-12-22
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pineda-Peña ACAndrea-Clemencia
2Hasegawa KKohei
3Pavot VVincent
4Berry CCatherine
5Combadière BBehazine
6Cortes-Garcia GGuadalupe
7McDermott ABAdrian B
8Sridhar SSaranya

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References224

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136454813Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.Sci Transl Med2023https://conductscience.org/library/papers/36454813PubMed
234525276SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.N Engl J Med2021https://conductscience.org/library/papers/34525276PubMed
333027962Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion.Int J Mol Sci2020https://conductscience.org/library/papers/33027962PubMed
49651253Visualization of specific B and T lymphocyte interactions in the lymph node.Science1998https://conductscience.org/library/papers/9651253PubMed
537822054Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study.J Med Virol2023https://conductscience.org/library/papers/37822054PubMed
638141632
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet Infect Dis2024https://conductscience.org/library/papers/38141632PubMed
734648302mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.Science2021https://conductscience.org/library/papers/34648302PubMed
836131022Long-primed germinal centres with enduring affinity maturation and clonal migration.Nature2022https://conductscience.org/library/papers/36131022PubMed
936155617Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.JAMA2022https://conductscience.org/library/papers/36155617PubMed
1036259394Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2.J Infect Dis2023https://conductscience.org/library/papers/36259394PubMed
1134706170Waning Immunity after the BNT162b2 Vaccine in Israel.N Engl J Med2021https://conductscience.org/library/papers/34706170PubMed
1235910658A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19.Front Microbiol2022https://conductscience.org/library/papers/35910658PubMed
1330312894From zero to sixty and back to zero again: the metabolic life of B cells.Curr Opin Immunol2019https://conductscience.org/library/papers/30312894PubMed
1429883414Immune History and Influenza Vaccine Effectiveness.Vaccines (Basel)2018https://conductscience.org/library/papers/29883414PubMed
1534043894Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.N Engl J Med2021https://conductscience.org/library/papers/34043894PubMed
1638395697SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.Immunity2024https://conductscience.org/library/papers/38395697PubMed
1732134478The Status of Vaccine Development Against the Human Cytomegalovirus.J Infect Dis2020https://conductscience.org/library/papers/32134478PubMed
1831904601Toward precision adjuvants: optimizing science and safety.Curr Opin Pediatr2020https://conductscience.org/library/papers/31904601PubMed
1937792377Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.JAMA Netw Open2023https://conductscience.org/library/papers/37792377PubMed
2036535326Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.Nature2023https://conductscience.org/library/papers/36535326PubMed

See all 224 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42944129Recombinant B87 and HLJ0504 VP2 Vaccines Protect Chickens Against Infectious Bursal Disease.Vet Sci2026https://conductscience.org/library/papers/42944129PubMed
42931403Navigating the Transition to RNA-Based Influenza Vaccines: A State-of-the-Art Review.Vaccines (Basel)2026https://conductscience.org/library/papers/42931403PubMed
42912726Immunoinformatics and reverse vaccinology design of self-amplifying RNA vaccine against marburg virus with structural dynamics and immune simulation analysis.PLoS One2026https://conductscience.org/library/papers/42912726PubMed
42826091Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42826091PubMed
42653476ZBP1 in Neuroinflammation and Neurodegeneration: Z-Nucleic-Acid Sensing, RHIM Signalling and Therapeutic Targeting.Int J Mol Sci2026https://conductscience.org/library/papers/42653476PubMed
42646726mRNA-1010 and the Future of Seasonal Influenza Prevention: Towards Next-Generation Respiratory Vaccination.Vaccines (Basel)2026https://conductscience.org/library/papers/42646726PubMed
42488666Vaccination-enabled immune readiness for checkpoint blockade.Front Immunol2026https://conductscience.org/library/papers/42488666PubMed
42457878Variant-specific and cross-reactive antibody responses following COVID-19 booster vaccinations and SARS-CoV-2 breakthrough infections.Sci Rep2026https://conductscience.org/library/papers/42457878PubMed
42439828Malaria serology for surveillance, insights into immunity, and vaccine development.Infect Immun2026https://conductscience.org/library/papers/42439828PubMed
42358960Soluble multi-epitope protein vaccination leverages antigen availability to drive CD8+ T cell immunity and tumor control.Front Immunol2026https://conductscience.org/library/papers/42358960PubMed
42188814
Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48.
Vaccines (Basel)2026https://conductscience.org/library/papers/42188814PubMed
42188779Recombinant Immunogens Designed by AI Epitope Prioritization Confer Protection Against Mycobacterium tuberculosis.Vaccines (Basel)2026https://conductscience.org/library/papers/42188779PubMed
42083894NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42083894PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41360809

GET https://conductscience.org/api/papers/v1/41360809/references?page=2